Contact

Address

Peter Doherty Institute, Parkville

Phone

83443159

Email

sharon.lewin@unimelb.edu.au

Credentials

Position
Director, Peter Doherty Institute
Infectious Diseases
Education
Doctor of Philosophy
Monash University
Bachelor of Medicine & Bachelor of Surgery
Monash University
ORCID

0000-0002-0330-8241

Prof. Sharon Lewin

Director, Peter Doherty Institute
Infectious Diseases
497 Scholarly works
115 Projects

HIGHLIGHTS

  • 2021

    Journal article

    The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
    DOI: 10.1097/QAD.0000000000002919
  • 2021

    Journal article

    Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV.
    DOI: 10.1038/s41467-021-24673-w
  • 2021

    Journal article

    Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    DOI: 10.1038/s41467-021-24577-9
  • 2021

    Journal article

    Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
    DOI: 10.1093/ofid/ofab239
  • 2021

    Research Grant

    COVID-19 Vaccine Biobank
  • 2019

    Research Grant

    ADDRESSING THE MAJOR CHALLENGES IN HIV VACCINE AND CURE RESEARCH
  • 2016

    Research Grant

    AUSTRALIAN PARTNERSHIP FOR PREPAREDNESS RESEARCH ON INFECTIOUS DISEASE EMERGENCIES (APPRISE)
Sharon Lewin

Latest Honours,
Awards and Fellowships

2019
Officer of the Order of Australia
2020
Appointment Expires on 11/05/2025 University of Melbourne
2014
The Gertrude Elion Distinguished Lecturer Award HIV DART
2014
Hadassah Australia 2014 Tikun Olam Award Hadassah Australia

RECENT SCHOLARLY WORKS

  • 2021

    Journal article

    The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency
    DOI: 10.3389/fgene.2021.680725
  • 2021

    Journal article

    Toll-like Receptor 7 Agonists in People Living With HIV: Implications for Immunotherapeutic Strategies for an HIV Cure.
    DOI: 10.1093/cid/ciaa1539
  • 2021

    Journal article

    Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B
    DOI: 10.12932/AP-050718-0365
  • 2021

    Journal article

    Therapeutics for COVID-19: established and in development
    DOI: 10.1071/MA20058
  • 2021

    Journal article

    Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
    DOI: 10.1016/j.lanwpc.2021.100115
  • 2021

    Journal article

    Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)
    DOI: 10.1093/cid/ciaa748

RECENT PROJECTS

  • 2006

    Research Contracts

    Development of a simple and rapid assay to determine HIV-1 viral fitness and co-receptor use of HIV-1 derived from patient blood Short title: FITNESS
  • 2020

    Research Contracts

    Sentinel Travellers and Research Preparedness for Emerging Infectious Diseases (SETREP-ID)